Stage is a prognostic factor for surgically treated patients with early-stage lip cancer for whom a 'wait and see' policy in terms of neck status has been implemented

Simple item page
dc.contributor.authorEskiizmir G.
dc.contributor.authorOzgur E.
dc.contributor.authorKaraca G.
dc.contributor.authorTemiz P.
dc.contributor.authorYanar N.H.
dc.contributor.authorOzyurt B.C.
dc.date.accessioned2024-07-22T08:10:24Z
dc.date.available2024-07-22T08:10:24Z
dc.date.issued2017
dc.description.abstractObjectives: To determine the locoregional control and survival rates (in terms of risk factors) of patients who underwent surgical resection of early-stage lip cancer and for whom a 'wait and see' policy in terms of neck status had been implemented. Methods: The sociodemographic data, tumour stage, tumour characteristics and histopathological features of 41 patients with early-stage lip cancer were evaluated. Factors predictive of survival and locoregional recurrence were analysed. The five-year overall survival and disease-free survival rates were determined, and the prognostic risk factors were compared. Results: The mean follow-up period was 60.5 months (range, 4-92 months). Age, sex, tumour stage, tumour thickness and volume, and perineural involvement were not predictive of locoregional recurrence or survival. Pathological tumour stage (T1 vs T2) was a prognostic factor for both five-year overall survival (87.3 vs 65.6 per cent, p = 0.042) and disease-free survival (88.6 vs 65.6 per cent, p = 0.037). Conclusion: Tumour stage was clearly a major factor affecting the prognosis of surgically treated patients with early-stage lip cancer for whom a 'wait and see' policy in terms of neck status had been implemented. Copyright © JLO (1984) Limited 2017.
dc.identifier.DOI-ID10.1017/S0022215117001669
dc.identifier.issn00222151
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/15226
dc.language.isoEnglish
dc.publisherCambridge University Press
dc.subjectAdult
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectDisease-Free Survival
dc.subjectFemale
dc.subjectHumans
dc.subjectLip Neoplasms
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectNeck
dc.subjectNeck Dissection
dc.subjectNeoplasm Staging
dc.subjectPrognosis
dc.subjectSurvival Analysis
dc.subjectTreatment Outcome
dc.subjectage
dc.subjectaged
dc.subjectArticle
dc.subjectcancer prognosis
dc.subjectcancer recurrence
dc.subjectcancer size
dc.subjectcancer staging
dc.subjectcancer survival
dc.subjectclinical article
dc.subjectdemography
dc.subjectdisease free survival
dc.subjectfemale
dc.subjectfollow up
dc.subjecthistopathology
dc.subjecthuman
dc.subjectlip cancer
dc.subjectlocal recurrence free survival
dc.subjectmale
dc.subjectoverall survival
dc.subjectperineural invasion
dc.subjectreference value
dc.subjectretrospective study
dc.subjectsex difference
dc.subjectwedge resection
dc.subjectadult
dc.subjectLip Neoplasms
dc.subjectmiddle aged
dc.subjectneck
dc.subjectneck dissection
dc.subjectpathology
dc.subjectprocedures
dc.subjectprognosis
dc.subjectsurvival analysis
dc.subjecttreatment outcome
dc.subjectvery elderly
dc.titleStage is a prognostic factor for surgically treated patients with early-stage lip cancer for whom a 'wait and see' policy in terms of neck status has been implemented
dc.typeArticle

Files

Collections

Scopus Koleksiyonu